Zhongchao, Inc. a holding company incorporated under the laws of the Cayman Islands, through its variable interest entity and subsidiaries, provides healthcare information, education, and training services to healthcare professionals and the public in China. Zhongchao commenced its operation, through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information and continuous learning and training opportunities for Chinese healthcare professionals. Zhongchao offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
Location of Key Operations
Marcum Bernstein & Pinchuck LLP
IPO (February 19, 2020)
Jing An, Shanghai, China
Pei Xu, Internal
July 1, 2021: Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management (prnewswire.com)
June 16, 2021: Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services (yahoo.com)
June 3, 2021: Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai (yahoo.com)
May 28, 2021: Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management (yahoo.com)
May 3, 2021: Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results (yahoo.com)
March 18, 2021: Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline
March 8, 2021: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm
February 24, 2021: Shareholder Notice: Investigation over Possible Securities Laws Violations by Zhongchao Inc.
January 13, 2021: Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts